# CART-EGFR-IL13Ra2 in EGFR Amplified Recurrent GBM

> **NCT05168423** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **University of Pennsylvania** · enrollment: 67 (actual)

## Conditions studied

- Glioblastoma

## Interventions

- **DRUG:** CART-EGFR-IL13Ra2 Cells

## Key facts

- **NCT ID:** NCT05168423
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-02-24
- **Primary completion:** 2039-12-19
- **Final completion:** 2039-12-19
- **Target enrollment:** 67 (ACTUAL)
- **Last updated:** 2026-04-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05168423

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05168423, "CART-EGFR-IL13Ra2 in EGFR Amplified Recurrent GBM". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05168423. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*